ClearPoint Neuro (CLPT) EPS (Diluted) Growth (1y) (2014 - 2026)
ClearPoint Neuro (CLPT) EPS (Diluted) Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -18.71% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.88% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 98.71% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 95.96% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 114.19% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -29.80% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | -48.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.71% |
| Dec 31, 2025 | -56.66% |
| Sep 30, 2025 | -14.95% |
| Jun 30, 2025 | -28.72% |
| Mar 31, 2025 | -33.46% |
| Dec 31, 2024 | 12.14% |
| Sep 30, 2024 | 34.36% |
| Jun 30, 2024 | 64.86% |
| Mar 31, 2024 | 63.75% |
| Dec 31, 2023 | -3.66% |
| Sep 30, 2023 | 39.09% |
| Jun 30, 2023 | 25.39% |
| Mar 31, 2023 | 6.33% |
| Dec 31, 2022 | 2.56% |
| Sep 30, 2022 | 46.92% |
| Jun 30, 2022 | 28.09% |
| Mar 31, 2022 | 61.83% |
| Dec 31, 2021 | 85.07% |
| Sep 30, 2021 | 70.43% |
| Jun 30, 2021 | 32.00% |